Nexeon MedSystems Inc.
Other OTCTotal Valuation
Nexeon MedSystems Inc. carries a market capitalization of 78,625.00, placing it among publicly traded companies globally. Its enterprise value stands at 19.63M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 78,625.00 |
| Enterprise Value | 19.63M |
Share Statistics
Nexeon MedSystems Inc. currently has 1.97M shares outstanding.
| Shares Outstanding | 1.97M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 1.60, and the price-to-book ratio stands at -2.31.
| PE Ratio | N/A |
| PS Ratio | 1.60 |
| PB Ratio | -2.31 |
| P/TBV Ratio | -22.68 |
| P/FCF Ratio | 22.66 |
| P/OCF Ratio | 24.92 |
Enterprise Valuation
| EV / Sales | 2.00 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 21.09 |
Financial Position
Nexeon MedSystems Inc. maintains a current ratio of 0.73, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 43.78, indicating elevated leverage, while an interest coverage ratio of -13.20 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.73 |
| Quick Ratio | 0.37 |
| Debt / Equity | 43.78 |
| Debt / EBITDA | -0.95 |
| Interest Coverage | -13.20 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -9.21 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 475.64 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.86 |
Taxes
| Income Tax | -576,224.00 |
| Effective Tax Rate | N/A |
Income Statement
Over the trailing twelve months, Nexeon MedSystems Inc. generated 9.82M in revenue and converted that into -1.65M in net income, yielding earnings per share of -0.84. EBITDA reached -4.20M, while operating income came in at -5.67M.
| Revenue | 9.82M |
| Gross Profit | 3.01M |
| Operating Income | -5.67M |
| Pretax Income | -2.22M |
| Net Income | -1.65M |
| EBITDA | -4.20M |
| EBIT | -5.67M |
| Earnings Per Share (EPS) | -0.84 |
Balance Sheet
Nexeon MedSystems Inc. holds 125,573.00 in cash and equivalents against 4.00M in total debt, resulting in a net debt position of 3.88M. Total book value stands at -6.81M, with working capital of -1.93M providing operational flexibility.
| Cash & Cash Equivalents | 125,573.00 |
| Total Debt | 4.00M |
| Net Debt | 3.88M |
| Equity (Book Value) | -6.81M |
| Book Value Per Share | -3.46 |
| Working Capital | -1.93M |
Cash Flow
Nexeon MedSystems Inc. produced 632,357.00 in operating cash flow over the past twelve months. After subtracting -63,083.00 in capital expenditures, free cash flow totaled 569,274.00 - equivalent to 0.29 per share.
| Operating Cash Flow | 632,357.00 |
| Capital Expenditures | -63,083.00 |
| Free Cash Flow | 569,274.00 |
| FCF Per Share | 0.29 |
Margins
Nexeon MedSystems Inc. operates with a gross margin of 30.66, reflecting its pricing power and cost economics. The operating margin of -57.69 and net profit margin of -16.84 provide insight into operational efficiency.
| Gross Margin | 30.66 |
| Operating Margin | -57.69 |
| Pretax Margin | -22.57 |
| Profit Margin | -16.84 |
| EBITDA Margin | -42.74 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 7.33 |
| FCF Yield | 4.41 |
Stock Splits
Nexeon MedSystems Inc.'s most recent stock split took place on June 28, 2018 with a 14:1 split ratio.
| Last Split Date | 6/28/2018 |
| Split Ratio | 14:1 |
Scores
Nexeon MedSystems Inc. posts an Altman Z-Score of -1.37, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1.37 |